Early initiation of antiretroviral therapy prevents HIV transmission to seronegative sexual partners

Thumbnail Image
Files
Anglemyer-Early_initiation_of_antiretrov.pdf (348.51 KB)
Authors
Rutherford, George W.
Anglemyer, Andrew
Subjects
Advisors
Date of Issue
2017-03
Date
Publisher
BMJ
Language
Abstract
In 2011, interim results from the HIV Prevention Trials Network (HPTN) 052 trial confirmed that early antiretroviral therapy (ART) markedly reduces HIV transmission in serodiscordant couples.1 This, along with evidence that therapeutic benefits accrue from starting ART earlier,1–3 led the WHO to recommend that all patients with HIV infection start ART as soon as possible after diagnosis.4 Cohen et al have now published a final analysis from their original HPTN 052 report.
Type
Article
Description
URI
https://hdl.handle.net/10945/59383
Series/Report No
Department
Organization
Identifiers
NPS Report Number
Sponsors
Funding
Format
1 p.
Citation
Rutherford, George W., and Andrew Anglemyer. "Early initiation of antiretroviral therapy prevents HIV transmission to seronegative sexual partners." Evidence-based medicine 22.1 (2017): 29.
Distribution Statement
Rights
This publication is a work of the U.S. Government as defined in Title 17, United States Code, Section 101. Copyright protection is not available for this work in the United States.
Collections
Publications